11th International Conference on Cryptococcus and Cryptococcosis (ICCC)

第十一届隐球菌和隐球菌病国际会议(ICCC)

基本信息

  • 批准号:
    10399173
  • 负责人:
  • 金额:
    $ 1.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-01 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT This proposal requests partial support for the 11th International Conference on Cryptococcus and Cryptococcosis (ICCC) to be held in Kampala, Uganda, January 10-14, 2022. Cryptococcosis accounts for 15% of AIDS-related deaths globally. Cryptococcal meningitis remains the most common neuroinfection among all adults in Sub-Saharan Africa and continues to be a major threat to a growing number of non-HIV immunocompromised persons. The broad and long-term goal of this ICCC is to bring together the world's leading researchers in this expanding field to foster cross-disciplinary discussions, research, and clinical collaborations to enhance our understanding of the mechanisms of Cryptococcus pathogenicity and best management of cryptococcosis. The specific aims of this meeting will be to convene leading experts whose expertise covers critical areas within this field, as well as early career and junior investigators, students, and postdocs. We anticipate hosting 300 participants. The program will be structured into 17 sessions covering the diverse properties and characteristics of the pathogen as well as host susceptibility and immunity, emphasizing what makes a normal host suddenly susceptible to this disease. Importantly, the conference will provide ample coverage of current and novel antifungals – ranging from pre-clinical development programs through ongoing/future clinical trials. Abstracts from junior investigators, graduate students, and postdoctoral fellows will be included among those selected for oral presentation. The conference will host two poster sessions which will permit all participants to actively contribute to these topics. Of the 17 session blocks, 12 blocks will be concurrent sessions to allow for smaller working groups to meet and more students / trainees to present their abstracts. The R13 resources will go towards supporting travel grant participation by graduate students and specifically under-represented minority scholars from US and Africa who present abstracts. We will seek parity with respect to women and minorities in the selection of speakers and organizing committee, starting with 2 of the 3 ICCC co-chairs being a woman or a minority. We will target at least ~40% of plenary speakers to be women and ~10% under-represented minorities. Childcare will be provided. The 11th ICCC is significant because focuses on an important infectious disease afflicting both immunocompromised and immunocompetent people. This is the only such conference that brings together basic scientists and clinical investigators who investigate cryptococcosis. This is the first time the conference will be held in Africa with objectives: 1) to build new US-African translational research collaborations; 2) to define the important clinical, translational, and basic science research agenda to forge new avenues for novel prevention and treatment strategies.
抽象的 该提案请求对第十一届隐球菌国际会议给予部分支持 隐球菌病 (ICCC) 将于 2022 年 1 月 10 日至 14 日在乌干达坎帕拉举行。隐球菌病占 全球 15% 的死亡与艾滋病相关。隐球菌性脑膜炎仍然是最常见的神经感染 在撒哈拉以南非洲地区的所有成年人中,这种疾病仍然是对越来越多的非艾滋病毒感染者的主要威胁 免疫功能低下的人。 ICCC 的广泛而长期的目标是汇集该领域世界领先的研究人员 扩大领域,促进跨学科讨论、研究和临床合作,以增强我们的能力 了解隐球菌致病机制和隐球菌病的最佳管理。 这次会议的具体目标是召集领先的专家,他们的专业知识涵盖关键领域 该领域内的各个领域,以及早期职业和初级研究人员、学生和博士后。我们 预计接待 300 名参与者。该计划将分为 17 个会议,涵盖不同的领域 病原体的特性和特征以及宿主的易感性和免疫力,强调 是什么让正常宿主突然容易感染这种疾病。重要的是,会议将提供 广泛涵盖当前和新型抗真菌药物——从临床前开发计划到 正在进行/未来的临床试验。初级研究员、研究生和博士后的摘要 将被列入被选中进行口头报告的人员之中。会议将举办两场海报展示会 这将使所有参与者积极为这些主题做出贡献。在 17 个会话块中,有 12 个块 将同时举行会议,以便较小的工作组能够开会,并允许更多的学生/受训者 展示他们的摘要。 R13 资源将用于支持毕业生参与旅行补助 来自美国和非洲的学生,特别是代表性不足的少数族裔学者,他们提交了摘要。 我们将在选择演讲者和组织活动时寻求对妇女和少数族裔的平等 委员会,首先,ICCC 的 3 名联合主席中有 2 名是女性或少数族裔。我们将至少瞄准 全体会议发言者中约 40% 为女性,约 10% 为代表性不足的少数族裔。将提供托儿服务。 第 11 届 ICCC 意义重大,因为它重点讨论了一种影响两国人民的重要传染病 免疫功能低下和免疫功能健全的人。这是唯一一次汇聚一堂的此类会议 研究隐球菌病的基础科学家和临床研究人员。这是第一次 会议将在非洲举行,目标是:1)建立新的美非转化研究 合作; 2) 确定重要的临床、转化和基础科学研究议程 新的预防和治疗策略的新途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David R Boulware其他文献

Management of advanced HIV disease in Africa
非洲艾滋病晚期的管理
  • DOI:
    10.1016/s2352-3018(23)00078-4
  • 发表时间:
    2023-06-01
  • 期刊:
  • 影响因子:
    13.000
  • 作者:
    Santiago Izco;Alberto L Garcia-Basteiro;David W Denning;David R Boulware;Adam Penn-Nicholson;Emilio Letang
  • 通讯作者:
    Emilio Letang
Experiences, challenges, gaps, and strategies for counselling persons presenting with advanced HIV-associated meningitis in Uganda
  • DOI:
    10.1186/s12981-025-00705-z
  • 发表时间:
    2025-02-19
  • 期刊:
  • 影响因子:
    2.500
  • 作者:
    Alisat Sadiq;Richard Kwizera;Tadeo K Kiiza;Peruth Ayebare;Cynthia Ahimbisibwe;Jane Frances Ndyetukira;David R Boulware;David B. Meya
  • 通讯作者:
    David B. Meya
Randomized trial of mechanotherapy for the treatment of stress urinary incontinence in women
机械疗法治疗女性压力性尿失禁的随机试验
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Nissrine A. Nakib;Suzette Sutherland;Kevin Hallman;Marcus Mianulli;David R Boulware
  • 通讯作者:
    David R Boulware
Advancing the chemotherapy of tuberculous meningitis: a consensus view
推进结核性脑膜炎的化疗:共识观点
  • DOI:
    10.1016/s1473-3099(24)00512-7
  • 发表时间:
    2025-01-01
  • 期刊:
  • 影响因子:
    31.000
  • 作者:
    Sean Wasserman;Joseph Donovan;Evelyne Kestelyn;James A Watson;Robert E Aarnoutse;James R Barnacle;David R Boulware;Felicia C Chow;Fiona V Cresswell;Angharad G Davis;Kelly E Dooley;Anthony A Figaji;Diana M Gibb;Julie Huynh;Darma Imran;Suzaan Marais;David B Meya;Usha K Misra;Manish Modi;Mihaja Raberahona;Robert J Wilkinson
  • 通讯作者:
    Robert J Wilkinson
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trials
用于隐球菌性脑膜炎死亡率的个性化风险预测工具以指导撒哈拉以南非洲的治疗分层:一项基于两项随机对照试验汇总分析的预后建模研究
  • DOI:
    10.1016/s2214-109x(25)00010-5
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    18.000
  • 作者:
    Thomas H A Samuels;Sile F Molloy;David S Lawrence;Angela Loyse;Cecilia Kanyama;Robert S Heyderman;Wai Shing Lai;Sayoki Mfinanga;Sokoine Lesikari;Duncan Chanda;Charles Kouanfack;Elvis Temfack;Olivier Lortholary;Mina C Hosseinipour;Adrienne K Chan;David B Meya;David R Boulware;Henry C Mwandumba;Graeme Meintjes;Conrad Muzoora;Rishi K Gupta
  • 通讯作者:
    Rishi K Gupta

David R Boulware的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David R Boulware', 18)}}的其他基金

Encochleated Oral Amphotericin for HIV-related Cryptococcal Meningitis Trial: Phase 3 Trial
包埋口服两性霉素治疗 HIV 相关隐球菌性脑膜炎试验:3 期试验
  • 批准号:
    10619788
  • 财政年份:
    2023
  • 资助金额:
    $ 1.7万
  • 项目类别:
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies
结核性脑膜炎:评估脑脊液免疫学以发现隐藏疾病和潜在的免疫调节疗法
  • 批准号:
    10335501
  • 财政年份:
    2021
  • 资助金额:
    $ 1.7万
  • 项目类别:
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies
结核性脑膜炎:评估脑脊液免疫学以发现隐藏疾病和潜在的免疫调节疗法
  • 批准号:
    10459614
  • 财政年份:
    2021
  • 资助金额:
    $ 1.7万
  • 项目类别:
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies
结核性脑膜炎:评估脑脊液免疫学以发现隐藏疾病和潜在的免疫调节疗法
  • 批准号:
    10675513
  • 财政年份:
    2021
  • 资助金额:
    $ 1.7万
  • 项目类别:
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial
包埋口服两性霉素治疗隐球菌性脑膜炎试验
  • 批准号:
    10163929
  • 财政年份:
    2019
  • 资助金额:
    $ 1.7万
  • 项目类别:
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial
包埋口服两性霉素治疗隐球菌性脑膜炎试验
  • 批准号:
    10364704
  • 财政年份:
    2019
  • 资助金额:
    $ 1.7万
  • 项目类别:
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)
隐球菌抗原筛查加舍曲林 (C-ASSERT)
  • 批准号:
    9271847
  • 财政年份:
    2016
  • 资助金额:
    $ 1.7万
  • 项目类别:
Phased Implementation of a Public Health Programme: Cryptococcal Screening and Treatment in South Africa
公共卫生计划的分阶段实施:南非的隐球菌筛查和治疗
  • 批准号:
    9232071
  • 财政年份:
    2016
  • 资助金额:
    $ 1.7万
  • 项目类别:
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)
隐球菌抗原筛查加舍曲林 (C-ASSERT)
  • 批准号:
    9925177
  • 财政年份:
    2016
  • 资助金额:
    $ 1.7万
  • 项目类别:
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)
隐球菌抗原筛查加舍曲林 (C-ASSERT)
  • 批准号:
    9914429
  • 财政年份:
    2016
  • 资助金额:
    $ 1.7万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.7万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 1.7万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 1.7万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 1.7万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 1.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 1.7万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 1.7万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 1.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 1.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 1.7万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了